Immune cells known as myeloid derived suppressor cells, which help cancer cells survive, have now been finally identified thanks to a new study.
The study, published by the Immunity journal, reports that cancer stem cells are thought to be resistant to current chemotherapy and radiation treatments, and researchers believe that killing the cancer stem cells is crucial for eliminating cancer, Prensa Latina reported Friday.
Tumors Use Sugar to Disable Immune Cells
Researchers at Washington University School of Medicine in St. Louis have learned that cancer cells' appetite for sugar may have serious consequences for immune cell function.
Advertisement
Researchers looked at cells from the most common and lethal type of ovarian cancer, a disease in which patients often become resistant to chemotherapy, causing the cancer to return.
The researchers also said that if a therapy to combat the function of these cells could be identified, it would be possible to eliminate the immune suppression that helps support the cancer.
Cancer is the uncontrolled growth of abnormal or malignant cells in the body that multiply autonomously, invading other tissues both near and far from the source.
Source: IANS
Cancer is the uncontrolled growth of abnormal or malignant cells in the body that multiply autonomously, invading other tissues both near and far from the source.
Source: IANS
Role of Brain's Immune Cells During Alzheimer's Disease Progression Studied
The brain's own immune cells, the microglia, surround the plaque deposits in the brain of Alzheimer's patients.
Advertisement
 Research Sheds Light on How Immune Cells Detect InfectionsResearchers have always puzzled as to how immune cells manage to sort through vast numbers of similar-looking proteins within the body to detect foreign invaders and fight infections. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable